Back to RGNX

UBS Group AG → RGNX

UBS Group AG RGNX Position History

REGENXBIO Inc. • Healthcare

Quarters held
14
Latest value
$137K
Q3 2026
Peak value
$2.7M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$395K
Q3 2025$2.1M
Q4 2025$288K
Q4 2025$2.7M
Q4 2025$10K
Q1 2026$152K
Q1 2026$1.8M
Q1 2026$164K
Q2 2026$176K
Q2 2026$2.5M
Q2 2026$274K
Q3 2026$128K
Q3 2026$1.5M
Q3 2026$137K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$137K18.2K——
Q3 2026$1.5M198.8K——
Q3 2026$128K17.0K——
Q2 2026$274K22.9K——
Q2 2026$2.5M212.4K——
Q2 2026$176K14.7K——
Q1 2026$164K19.6K——
Q1 2026$1.8M219.8K——
Q1 2026$152K18.1K——
Q4 2025$10K685——
Q4 2025$2.7M186.0K——
Q4 2025$288K20.0K——
Q3 2025$2.1M221.5K——
Q3 2025$395K40.9K——

Other funds holding RGNX

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B